Cargando…
Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura
Acquired thrombotic thrombocytopenic purpura (TTP) is an uncommon microangiopathic disorder that can have variable presentations and can be precipitated by a multitude of stressors to the body, most commonly sepsis. TTP is caused by a deficiency of ADAMTS13 leading to intravascular clotting causing...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520316/ https://www.ncbi.nlm.nih.gov/pubmed/34667692 http://dx.doi.org/10.7759/cureus.18017 |
_version_ | 1784584646356369408 |
---|---|
author | Jackson, Logan J Fischer, Hannah Abdelsayed, Nardine Carter, Mary |
author_facet | Jackson, Logan J Fischer, Hannah Abdelsayed, Nardine Carter, Mary |
author_sort | Jackson, Logan J |
collection | PubMed |
description | Acquired thrombotic thrombocytopenic purpura (TTP) is an uncommon microangiopathic disorder that can have variable presentations and can be precipitated by a multitude of stressors to the body, most commonly sepsis. TTP is caused by a deficiency of ADAMTS13 leading to intravascular clotting causing thrombocytopenia and microangiopathic hemolytic anemia. TTP can be associated with various other pathologic conditions. One such rare association has been reported with diabetic ketoacidosis (DKA). Here, we present an even less appreciated presentation in association with DKA. A 62-year-old African American male with previously diagnosed prediabetes presented with DKA and developed hemodynamically significant bleeding. He was confirmed to have TTP that responded to plasmapheresis. TTP is a life-threatening illness if not treated urgently with plasmapheresis with or without rituximab. As acquired TTP most commonly occurs during stress on the body, it is important to treat the underlying stressor. Early identification and initiation of appropriate interventions are crucial to reducing mortality associated with TTP. Furthermore, we need to appreciate less commonly associated conditions such as DKA among patients. |
format | Online Article Text |
id | pubmed-8520316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-85203162021-10-18 Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura Jackson, Logan J Fischer, Hannah Abdelsayed, Nardine Carter, Mary Cureus Endocrinology/Diabetes/Metabolism Acquired thrombotic thrombocytopenic purpura (TTP) is an uncommon microangiopathic disorder that can have variable presentations and can be precipitated by a multitude of stressors to the body, most commonly sepsis. TTP is caused by a deficiency of ADAMTS13 leading to intravascular clotting causing thrombocytopenia and microangiopathic hemolytic anemia. TTP can be associated with various other pathologic conditions. One such rare association has been reported with diabetic ketoacidosis (DKA). Here, we present an even less appreciated presentation in association with DKA. A 62-year-old African American male with previously diagnosed prediabetes presented with DKA and developed hemodynamically significant bleeding. He was confirmed to have TTP that responded to plasmapheresis. TTP is a life-threatening illness if not treated urgently with plasmapheresis with or without rituximab. As acquired TTP most commonly occurs during stress on the body, it is important to treat the underlying stressor. Early identification and initiation of appropriate interventions are crucial to reducing mortality associated with TTP. Furthermore, we need to appreciate less commonly associated conditions such as DKA among patients. Cureus 2021-09-16 /pmc/articles/PMC8520316/ /pubmed/34667692 http://dx.doi.org/10.7759/cureus.18017 Text en Copyright © 2021, Jackson et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Jackson, Logan J Fischer, Hannah Abdelsayed, Nardine Carter, Mary Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura |
title | Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura |
title_full | Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura |
title_fullStr | Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura |
title_full_unstemmed | Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura |
title_short | Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura |
title_sort | diabetic ketoacidosis: possible cause of thrombotic thrombocytopenic purpura |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520316/ https://www.ncbi.nlm.nih.gov/pubmed/34667692 http://dx.doi.org/10.7759/cureus.18017 |
work_keys_str_mv | AT jacksonloganj diabeticketoacidosispossiblecauseofthromboticthrombocytopenicpurpura AT fischerhannah diabeticketoacidosispossiblecauseofthromboticthrombocytopenicpurpura AT abdelsayednardine diabeticketoacidosispossiblecauseofthromboticthrombocytopenicpurpura AT cartermary diabeticketoacidosispossiblecauseofthromboticthrombocytopenicpurpura |